Back
Range Cancer Therapeutics ETF Vs. Lantheus Holdings Industry Stock Comparison
Buy
63
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.58
Seasonality Move:
8.86%
Sell
18
LNTH
Lantheus Holdings
Last Price:
88.35
Seasonality Move:
-1.72%
Buy
63
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.80. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CNCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Lantheus Holdings (LNTH)
is a Sell
Is Lantheus Holdings a Buy, Sell or Hold?
- The current Lantheus Holdings [LNTH] share price is $91.13. The Score for LNTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- LNTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.
LNTH Stock Price Chart
What is Lantheus Holdings's stock price today?
-
The Lantheus Holdings share price today is $91.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LNTH is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 61.86 | Buy |
| Chaikin Money Flow: | -736 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.64 - 15.32) | Buy |
| Bollinger Bands (100): | (14.01 - 15.41) | Buy |
LNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 29.37 | Sell |
| Chaikin Money Flow: | -2309062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.1 | Buy |
| 20-day SMA: | 15.08 | Buy |
| 50-day SMA: | 15.03 | Buy |
| 200-day SMA: | 15.07 | Buy |
| 8-day EMA: | 15.25 | Buy |
| 20-day EMA: | 15.09 | Buy |
| 50-day EMA: | 14.98 | Buy |
| 200-day EMA: | 14.6 | Buy |
LNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.62 | Sell |
| 20-day SMA: | 110.31 | Sell |
| 50-day SMA: | 107.99 | Sell |
| 200-day SMA: | 84.39 | Buy |
| 8-day EMA: | 107.29 | Sell |
| 20-day EMA: | 108.9 | Sell |
| 50-day EMA: | 107.18 | Sell |
| 200-day EMA: | 91.45 | Sell |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lantheus Holdings Earnings Growth & LNTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $0.30 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lantheus Holdings Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||